BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 18815812)

  • 1. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.
    Kim MP; Park SI; Kopetz S; Gallick GE
    Cell Tissue Res; 2009 Jan; 335(1):249-59. PubMed ID: 18815812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of angiogenesis and vascular permeability by Src family kinases: opportunities for therapeutic treatment of solid tumors.
    Park SI; Shah AN; Zhang J; Gallick GE
    Expert Opin Ther Targets; 2007 Sep; 11(9):1207-17. PubMed ID: 17845146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel roles of Src in cancer cell epithelial-to-mesenchymal transition, vascular permeability, microinvasion and metastasis.
    Patel A; Sabbineni H; Clarke A; Somanath PR
    Life Sci; 2016 Jul; 157():52-61. PubMed ID: 27245276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel patented SRC kinase inhibitor.
    Lu XL; Liu XY; Cao X; Jiao BH
    Curr Med Chem; 2012; 19(12):1821-9. PubMed ID: 22414081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the cellular roles of Fyn-related kinase (FRK): implications in cancer biology.
    Goel RK; Lukong KE
    Cancer Metastasis Rev; 2016 Jun; 35(2):179-99. PubMed ID: 27067725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role for Lyn kinase in strengthening endothelial integrity and barrier function.
    Han J; Zhang G; Welch EJ; Liang Y; Fu J; Vogel SM; Lowell CA; Du X; Cheresh DA; Malik AB; Li Z
    Blood; 2013 Dec; 122(25):4140-9. PubMed ID: 24108461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of endothelial permeability by Src kinase signaling: vascular leakage versus transcellular transport of drugs and macromolecules.
    Hu G; Place AT; Minshall RD
    Chem Biol Interact; 2008 Jan; 171(2):177-89. PubMed ID: 17897637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eph as a target in inflammation.
    Ieguchi K
    Endocr Metab Immune Disord Drug Targets; 2015; 15(2):119-28. PubMed ID: 25772170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of long-term endothelial-barrier integrity is conditional to the cross-talk between Akt and Src signaling.
    Gao F; Sabbineni H; Artham S; Somanath PR
    J Cell Physiol; 2017 Oct; 232(10):2599-2609. PubMed ID: 28075016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of Src family kinases and therapeutic implications of their modulators.
    Kumar A; Jaggi AS; Singh N
    Fundam Clin Pharmacol; 2015 Apr; 29(2):115-30. PubMed ID: 25545125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric networks governing regulation and catalysis of Src-family protein tyrosine kinases: implications for disease-associated kinases.
    Cheng HC; Johnson TM; Mills RD; Chong YP; Chan KC; Culvenor JG
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):93-101. PubMed ID: 19566834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress of SRC family kinase inhibitors as anticancer agents.
    Cao X; You QD; Li ZY; Wang XJ; Lu XY; Liu XR; Xu D; Liu B
    Mini Rev Med Chem; 2008 Sep; 8(10):1053-63. PubMed ID: 18782057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capsiate, a nonpungent capsaicin-like compound, inhibits angiogenesis and vascular permeability via a direct inhibition of Src kinase activity.
    Pyun BJ; Choi S; Lee Y; Kim TW; Min JK; Kim Y; Kim BD; Kim JH; Kim TY; Kim YM; Kwon YG
    Cancer Res; 2008 Jan; 68(1):227-35. PubMed ID: 18172315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent progress of Src SH2 and SH3 inhibitors as anticancer agents.
    Lu XL; Cao X; Liu XY; Jiao BH
    Curr Med Chem; 2010; 17(12):1117-24. PubMed ID: 20158477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold nanoparticles inhibit vascular endothelial growth factor-induced angiogenesis and vascular permeability via Src dependent pathway in retinal endothelial cells.
    Kalishwaralal K; Sheikpranbabu S; BarathManiKanth S; Haribalaganesh R; Ramkumarpandian S; Gurunathan S
    Angiogenesis; 2011 Mar; 14(1):29-45. PubMed ID: 21061058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Src in solid tumors.
    Wheeler DL; Iida M; Dunn EF
    Oncologist; 2009 Jul; 14(7):667-78. PubMed ID: 19581523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of SRC family kinases reduces myeloid-derived suppressor cells in head and neck cancer.
    Mao L; Deng WW; Yu GT; Bu LL; Liu JF; Ma SR; Wu L; Kulkarni AB; Zhang WF; Sun ZJ
    Int J Cancer; 2017 Mar; 140(5):1173-1185. PubMed ID: 27798955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Src family kinases in tumor progression and metastasis.
    Summy JM; Gallick GE
    Cancer Metastasis Rev; 2003 Dec; 22(4):337-58. PubMed ID: 12884910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src signaling in cancer invasion.
    Guarino M
    J Cell Physiol; 2010 Apr; 223(1):14-26. PubMed ID: 20049846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ability of an ethanol extract of Cinnamomum cassia to inhibit Src and spleen tyrosine kinase activity contributes to its anti-inflammatory action.
    Yu T; Lee S; Yang WS; Jang HJ; Lee YJ; Kim TW; Kim SY; Lee J; Cho JY
    J Ethnopharmacol; 2012 Jan; 139(2):566-73. PubMed ID: 22155395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.